PHILADELPHIA—ERT recently made a significant enhancement to MasterScope, its flagship platform for centralized respiratory clinical trials, and says it is now the industry’s first and only multi-language solution. MasterScope supports any clinical trial requiring spirometry measurements, and multilingual abilities enable users to save time, reduce the risk of protocol compliance errors and improve overall data quality by utilizing their native tongue.

 

“Respiratory trials are highly complex, requiring investigative site personnel to guide patients through precise maneuvers in order to collect accurate data that supports drug efficacy and safety claims,” said Achim Schülke, executive vice president, Respiratory Solutions at ERT. “Assuming all site personnel and patients can comprehend English well enough to accurately follow these workflows is impractical. With these enhancements to MasterScope, sponsors running global cardiopulmonary trials can now add native language capabilities to reduce another level of risk while increasing site compliance.”